Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Neutral
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Strong Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
China SXT Pharmaceuticals, Inc. Ordinary Shares (SXTC)
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/04/2019
Market Cap
3,476,090
Shares Outstanding
570,000
Weighted SO
565,533
Total Employees
N/A
Upcoming Earnings
N/A
Beta
1.1210
Last Div
0.0000
Range
0.925-9.375
Chg
-0.0300
Avg Vol
571917
Mkt Cap
3476090
Exch
NASDAQ
Country
CN
Phone
86 523 8629 8290
DCF Diff
-9.7713
DCF
11.6213
Div Yield
0.0000
P/S
1.5998
EV Multiple
0.2660
P/FV
0.0988
Div Yield %
0.0000
P/E
-0.0264
PEG
-0.0003
Payout
0.0000
Current Ratio
1.4669
Quick Ratio
1.4037
Cash Ratio
1.2462
DSO
215.8488
DIO
140.8512
Op Cycle
356.7000
DPO
318.8274
CCC
37.8726
Gross Margin
0.3067
Op Margin
-8.5056
Pretax Margin
-8.7374
Net Margin
-8.7374
Eff Tax Rate
0.0000
ROA
-1.3014
ROE
-2.2924
ROCE
-3.4301
NI/EBT
1.0000
EBT/EBIT
1.0273
EBIT/Rev
-8.5056
Debt Ratio
0.2019
D/E
0.5803
LT Debt/Cap
0.0206
Total Debt/Cap
0.3672
Int Coverage
-199.8118
CF/Debt
-0.1361
Equity Multi
2.8737
Rec Turnover
1.6910
Pay Turnover
1.1448
Inv Turnover
2.5914
FA Turnover
2.0303
Asset Turnover
0.1489
OCF/Share
-0.7996
FCF/Share
-0.9005
Cash/Share
22.8630
OCF/Sales
-0.1846
FCF/OCF
1.1261
CF Coverage
-0.1361
ST Coverage
-0.1412
CapEx Coverage
-7.9295
Div&CapEx Cov
-7.9295
P/BV
0.0988
P/B
0.0988
P/S
1.5998
P/E
-0.0264
P/FCF
-7.6981
P/OCF
-1.2506
P/CF
-1.2506
PEG
-0.0003
P/S
1.5998
EV Multiple
0.2660
P/FV
0.0988
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Revenue | 1.43M | ▲ 7.01M | ▼ 5.16M | ▼ -9.33M | ▼ -11.50M | ▲ 763.39K | ▲ 939.58K |
Cost Of Revenue | 620.69K | ▲ 2.40M | ▲ 2.46M | ▲ 3.44M | ▲ 4.03M | ▼ 426.80K | ▲ 753.99K |
Gross Profit | 812.03K | ▲ 4.61M | ▼ 2.70M | ▼ -12.77M | ▼ -15.53M | ▲ 336.59K | ▼ 185.59K |
Gross Profit Ratio | 0.57 | ▲ 0.66 | ▼ 0.52 | ▲ 1.37 | ▼ 1.35 | ▼ 0.44 | ▼ 0.20 |
Research And Development Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General And Administrative Expenses | 511.98K | ▲ 2.84M | ▲ 4.04M | ▲ 4.27M | ▼ 2.20M | ▼ 2.16M | ▲ 4.73M |
Selling And Marketing Expenses | 0.00 | 0.00 | ▲ 5.63M | ▼ -1.59M | ▲ -924.54K | ▲ 57.64K | ▲ 88.48K |
Selling General And Administrative Expenses | 511.98K | ▲ 2.84M | ▲ 9.67M | ▼ -11.17M | ▲ -8.44M | ▲ 4.79M | ▲ 9.53M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 511.98K | ▲ 2.84M | ▲ 9.67M | ▼ -11.17M | ▲ -8.44M | ▲ 4.79M | ▲ 9.53M |
Cost And Expenses | 1.13M | ▲ 5.24M | ▲ 12.13M | ▼ -7.73M | ▲ -4.41M | ▲ 5.22M | ▲ 10.29M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 46.25K | ▼ 0.00 |
Interest Expense | -1.27K | ▼ -5.17K | ▼ -3.35M | ▲ 1.98M | ▲ 3.56M | ▼ 92.49K | ▼ 0.00 |
Depreciation And Amortization | 29.76K | ▼ 16.79K | ▲ 198.30K | ▼ -289.76K | -289.76K | ▲ 140.20K | ▼ 102.75K |
Ebitda | 315.23K | ▲ 1.79M | ▼ -13.54M | ▲ 6.92M | ▼ 4.99M | ▼ -4.32M | ▼ -9.25M |
Ebitda Ratio | 0.22 | ▲ 0.25 | ▼ -2.62 | ▲ -0.74 | ▲ -0.43 | ▼ -5.65 | ▼ -9.84 |
Operating Income | 300.05K | ▲ 1.77M | ▼ -6.97M | ▲ 2.42M | ▼ 1.28M | ▼ -4.46M | ▼ -9.35M |
Operating Income Ratio | 0.21 | ▲ 0.25 | ▼ -1.35 | ▲ -0.26 | ▲ -0.11 | ▼ -5.84 | ▼ -9.95 |
Total Other Income Expenses Net | -13.32K | ▲ 21.96K | ▼ -3.42M | ▲ 2.43M | ▼ 1.11M | ▼ 16.90K | ▼ -347.14K |
Income Before Tax | 286.73K | ▲ 1.79M | ▼ -10.39M | ▲ 4.85M | ▼ 2.38M | ▼ -4.44M | ▼ -9.70M |
Income Before Tax Ratio | 0.20 | ▲ 0.26 | ▼ -2.01 | ▲ -0.52 | ▲ -0.21 | ▼ -5.82 | ▼ -10.32 |
Income Tax Expense | 104.87K | ▲ 252.23K | ▼ -101.72K | ▲ -75.34K | ▼ -596.16K | ▲ 3.00 | ▼ 0.00 |
Net Income | 181.87K | ▲ 1.54M | ▼ -10.29M | ▲ 5.31M | ▼ 2.32M | ▼ -4.44M | ▼ -9.70M |
Net Income Ratio | 0.13 | ▲ 0.22 | ▼ -1.99 | ▲ -0.57 | ▲ -0.20 | ▼ -5.82 | ▼ -10.32 |
Eps | 17.68 | ▲ 144.33 | ▼ -769.76 | ▲ 184.47 | ▼ 44.58 | ▼ -10.29 | ▼ -19.34 |
Eps Diluted | 17.68 | ▲ 145.65 | ▼ -769.76 | ▲ 184.47 | ▼ 44.58 | ▼ -10.29 | ▼ -19.34 |
Weighted Average Shs Out | 10.28K | ▲ 10.67K | ▲ 13.37K | ▲ 28.78K | ▲ 52.08K | ▲ 431.63K | ▲ 501.47K |
Weighted Average Shs Out Dil | 10.28K | ▲ 10.57K | ▲ 13.37K | ▲ 28.78K | ▲ 52.08K | ▲ 431.63K | ▲ 501.47K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 560.25K | ▲ 9.13M | ▼ 7.29M | ▲ 13.33M | ▲ 15.52M | ▲ 17.37M | ▼ 11.47M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 560.25K | ▲ 9.13M | ▼ 7.29M | ▲ 13.33M | ▲ 15.52M | ▲ 17.37M | ▼ 11.47M |
Net Receivables | 3.91M | ▲ 4.93M | ▲ 10.65M | ▼ 7.77M | ▼ 5.53M | ▼ 1.58M | ▼ 1.28M |
Inventory | 1.27M | ▼ 1.01M | ▼ 892.77K | ▼ 859.70K | ▲ 1.02M | ▼ 531.25K | ▲ 581.32K |
Other Current Assets | 37.21K | ▼ 36.72K | ▲ 144.35K | ▲ 180.37K | ▲ 288.94K | ▼ 46.30K | ▲ 164.08K |
Total Current Assets | 6.10M | ▲ 15.59M | ▲ 19.64M | ▲ 23.23M | ▼ 22.45M | ▼ 19.52M | ▼ 13.50M |
Property Plant Equipment Net | 1.49M | ▲ 1.81M | ▲ 1.90M | ▼ 1.79M | ▼ 1.59M | ▼ 1.27M | ▼ 1.07M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 60.67K | ▲ 61.10K | ▼ 50.05K | ▼ 45.80K | ▼ 38.76K | ▼ 27.87K | ▼ 22.51K |
Goodwill And Intangible Assets | 60.67K | ▲ 61.10K | ▼ 50.05K | ▼ 45.80K | ▼ 38.76K | ▼ 27.87K | ▼ 22.51K |
Long Term Investments | -6.17K | ▼ -13.50K | ▼ -112.85K | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 6.17K | ▲ 13.50K | ▲ 112.84K | ▲ 321.44K | ▼ 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 6.17K | ▲ 13.50K | ▲ 112.85K | ▲ 9.16M | ▲ 9.46M | ▼ 8.74M | ▼ -1.00 |
Total Non Current Assets | 1.56M | ▲ 1.88M | ▲ 2.07M | ▲ 11.31M | ▼ 11.09M | ▼ 10.03M | ▼ 1.09M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 7.66M | ▲ 17.47M | ▲ 21.70M | ▲ 34.55M | ▼ 33.55M | ▼ 29.55M | ▼ 14.59M |
Account Payables | 2.41M | ▼ 1.69M | ▲ 1.94M | ▼ 1.46M | ▲ 1.48M | ▼ 1.38M | ▼ 1.32M |
Short Term Debt | 385.12K | ▼ 261.15K | ▲ 6.69M | ▼ 37.12K | ▲ 2.05M | ▲ 3.39M | ▼ 2.84M |
Tax Payables | 870.47K | ▲ 1.06M | ▼ 986.84K | ▲ 1.16M | ▲ 1.17M | ▼ 1.10M | ▼ 1.04M |
Deferred Revenue | 292.95K | ▼ 57.55K | ▲ 298.04K | ▼ 257.45K | ▼ 77.37K | ▲ 165.53K | ▲ 190.19K |
Other Current Liabilities | 1.29M | ▲ 4.32M | ▼ 3.34M | ▲ 16.83M | ▼ 13.52M | ▼ 9.56M | ▼ 4.85M |
Total Current Liabilities | 4.37M | ▲ 6.32M | ▲ 12.26M | ▲ 18.58M | ▼ 17.12M | ▼ 14.50M | ▼ 9.20M |
Long Term Debt | 0.00 | ▲ 41.71K | ▼ 36.51K | ▼ 6.29K | ▼ 0.00 | ▲ 365.82K | ▼ 106.58K |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 0.00 | ▼ -4.00 | ▲ 0.00 | 0.00 | ▲ 3.61M | ▼ 0.00 | ▲ 204.94K |
Total Non Current Liabilities | 0.00 | ▲ 41.71K | ▼ 36.51K | ▼ 6.29K | ▲ 3.61M | ▼ 365.82K | ▼ 311.51K |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -3.61M | ▲ 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 306.05K | ▼ 204.94K |
Total Liabilities | 4.37M | ▲ 6.36M | ▲ 12.30M | ▲ 18.59M | ▼ 17.12M | ▼ 14.86M | ▼ 9.51M |
Preferred Stock | 5.00 | ▼ 2.00 | ▲ 3.00 | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 20.00K | ▲ 22.71K | ▲ 34.67K | ▲ 62.06K | ▲ 162.47K | ▲ 913.79K | ▲ 1.45M |
Retained Earnings | 1.54M | ▲ 3.08M | ▼ -7.20M | ▼ -9.95M | ▼ -15.69M | ▼ -21.61M | ▼ -31.31M |
Accumulated Other Comprehensive Income Loss | 257.37K | ▼ 50.40K | ▼ -590.66K | ▲ 527.79K | ▲ 956.14K | ▼ -197.57K | ▼ -1.02M |
Other Total Stockholders Equity | 1.46M | ▲ 7.95M | ▲ 17.16M | ▲ 25.32M | ▲ 30.99M | ▲ 35.59M | ▲ 35.95M |
Total Stockholders Equity | 3.29M | ▲ 11.11M | ▼ 9.40M | ▲ 15.96M | ▲ 16.42M | ▼ 14.69M | ▼ 5.08M |
Total Equity | 3.29M | ▲ 11.11M | ▼ 9.40M | ▲ 15.96M | ▲ 16.42M | ▼ 14.69M | ▼ 5.08M |
Total Liabilities And Stockholders Equity | 7.66M | ▲ 17.47M | ▲ 21.70M | ▲ 34.55M | ▼ 33.55M | ▼ 29.55M | ▼ 14.59M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 7.66M | ▲ 17.47M | ▲ 21.70M | ▲ 34.55M | ▼ 33.55M | ▼ 29.55M | ▼ 14.59M |
Total Investments | -6.17K | ▼ -13.50K | ▼ -112.85K | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 385.12K | ▼ 261.15K | ▲ 6.72M | ▼ 43.41K | ▲ 2.05M | ▲ 3.76M | ▼ 3.15M |
Net Debt | -175.13K | ▼ -8.87M | ▲ -563.16K | ▼ -13.29M | ▼ -13.48M | ▼ -13.61M | ▲ -8.31M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2020 | 2021 | 2022 | 2023 | 2023 | 1970 | |
---|---|---|---|---|---|---|---|
Net Income | 181.87K | ▼ -10.29M | ▲ 6.67M | ▼ 3.68M | ▼ -4.44M | ▼ -9.70M | ▼ |
Depreciation And Amortization | 29.76K | ▲ 198.30K | ▼ 25.89K | ▼ 484.00 | ▲ 140.20K | ▼ 102.75K | ▼ |
Deferred Income Tax | -5.85K | ▼ -101.72K | ▲ -85.11K | ▲ 435.72K | ▲ 750.50K | ▼ 0.00 | |
Stock Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 138.64K | ▼ 0.00 | |
Change In Working Capital | 1.93M | ▲ 3.43M | ▼ -6.89M | -6.89M | ▲ 1.17M | ▼ 315.76K | ▼ |
Accounts Receivables | -137.03K | ▲ 748.68K | ▼ -356.69K | ▲ 994.02K | ▲ 1.29M | ▼ -72.97K | ▼ |
Inventory | -42.45K | ▲ 80.32K | ▼ 750.00 | ▼ -218.67K | ▲ 128.71K | ▼ -38.56K | ▼ |
Accounts Payables | 492.40K | ▼ 18.28K | ▼ -1.13M | ▲ -533.47K | ▲ -244.28K | ▲ 19.35K | ▼ |
Other Working Capital | 1.62M | ▲ 2.58M | ▼ -5.40M | ▼ -7.13M | ▲ -612.00 | ▲ 407.93K | ▼ |
Other Non Cash Items | -10.00 | ▲ 9.72M | ▼ -6.13M | ▲ -2.05M | ▲ 2.71M | ▲ 9.00M | ▼ |
Net Cash Provided By Operating Activities | 2.13M | ▲ 2.96M | ▼ -6.41M | ▲ -4.82M | ▲ 468.37K | ▼ -579.57K | ▼ |
Investments In Property Plant And Equipment | -996.07K | ▲ -32.94K | ▲ 1.01M | ▲ 1.03M | ▼ -50.57K | ▲ 0.00 | |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Investing Activities | -627.20K | ▲ 24.11K | ▼ -5.18M | ▲ 557.51K | ▼ -1.04K | ▲ 19.64K | ▼ |
Net Cash Used For Investing Activities | -1.62M | ▲ -8.83K | ▼ -4.17M | ▲ 1.59M | ▼ -51.61K | ▲ 19.64K | ▼ |
Debt Repayment | 0.00 | 0.00 | ▼ -137.25K | -137.25K | ▼ -3.58M | ▲ -120.38K | ▼ |
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.19M | ▼ 0.00 | |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Financing Activities | -4.11K | ▼ -3.89M | ▲ 16.30M | ▼ 5.49M | ▲ 8.24M | ▼ -4.58M | ▼ |
Net Cash Used Provided By Financing Activities | -4.11K | ▼ -3.89M | ▲ 16.17M | ▼ 5.35M | ▲ 14.01M | ▼ -4.46M | ▼ |
Effect Of Forex Changes On Cash | 29.40K | ▼ -97.25K | ▲ 67.85K | 67.85K | ▼ -20.14K | ▼ -440.90K | ▼ |
Net Change In Cash | 536.02K | ▼ -1.04M | ▲ 5.65M | ▼ 2.18M | ▲ 14.39M | ▼ -5.90M | ▼ |
Cash At End Of Period | 560.25K | ▲ 7.21M | ▲ 13.36M | ▲ 15.57M | ▲ 17.37M | ▼ 11.47M | ▼ |
Cash At Beginning Of Period | 24.23K | ▲ 8.25M | ▼ 7.71M | ▲ 13.39M | ▼ 2.98M | ▲ 17.37M | ▼ |
Operating Cash Flow | 2.13M | ▲ 2.96M | ▼ -6.41M | ▲ -4.82M | ▲ 468.37K | ▼ -579.57K | ▼ |
Capital Expenditure | -996.07K | ▲ -32.94K | ▲ 1.01M | ▲ 1.03M | ▼ -50.57K | ▲ 0.00 | |
Free Cash Flow | 1.14M | ▲ 2.93M | ▼ -5.40M | ▲ -3.80M | ▲ 417.80K | ▼ -579.57K | ▼ |